Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

RX

- Prescription Medicines

ATENOLOL ARENA 50 mg

Cardioselective beta-blocker indicated in the treatment of arterial hypertension and angina pectoris

Tablets

50 mg

See details

ATORVASTATINA ARENA 10 mg

Drug from the statin class, indicated for cholesterol reduction and prevention of cardiovascular diseases

Film-coated tablets

10 mg

See details

ATORVASTATINA ARENA 20 mg

Drug from the statin class, indicated for cholesterol reduction and prevention of cardiovascular diseases

Film-coated tablets

20 mg

See details

ATORVASTATINA ARENA 40 mg

Drug from the statin class, indicated for cholesterol reduction and prevention of cardiovascular diseases

Film-coated tablets

40 mg

See details

ATORVASTATINA ARENA 80 mg

Drug from the statin class, indicated for cholesterol reduction and prevention of cardiovascular diseases

Film-coated tablets

80 mg

See details

AZITROMICINA ARENA 500 mg

Antibiotic from the macrolide class, with broad spectrum, indicated in respiratory, ENT and skin infections

Film-coated tablets

500 mg

See details

BEZAFIBRAT ARENA 200 mg

Lipid-lowering drug from the fibrate class, indicated for reducing triglycerides and cholesterol

Tablets

200 mg

See details

BIDIAB 400 mg/2,5 mg capsule

Combination of two oral antidiabetics for blood glucose control in type 2 diabetes mellitus

Capsules

400 mg/2,5 mg

See details

BITRIM 400 mg/80 mg

Combined antibiotic (cotrimoxazole) indicated in urinary tract and respiratory tract infections

Tablets

400 mg/80 mg

See details